FINN Partners and Hyderus unite to create global health communications and policy practice
Global independent marketing and communications agency FINN Partners announced today that Hyderus, an international, health-focused communications and policy firm, joins FINN.
Co-founders Mark Chataway and Christopher Nial join FINN and take leadership positions in the agency's global health practice and will co-lead its EMEA public health group. Both will report to Gil Bashe, chair global health and purpose.
In their new roles, Chataway and Nial will work closely with Fern Lazar, managing partner and global health practice lead, and Washington, DC-based Richard Hatzfeld, senior partner and global public health lead. Both Chataway and Nial become EMEA public health leads in the global health practice and members of the agency's global health practice leadership team, which Lazar facilitates.
Well-known for its global work in public health, health policy strategy, drug development and marketing communications, risk perception and crisis management, Hyderus will now be branded "Hyderus, a FINN Partners company.”
The agency becomes part of the FINN EMEA region, overseen by Chantal Bowman-Boyles, managing partner, who also leads FINN efforts throughout Europe. There are no staff redundancies or client conflicts.
“FINN has been at the forefront of championing health innovation in advanced and emerging economies,” notes Chataway, who becomes a FINN managing partner.
“During the past year, Hyderus has worked closely with FINN colleagues in EMEA and Asia on important vaccine access and public health initiatives. We’ve also worked on changes in European health delivery that can impact the lives of millions of people and the prosperity of countries. This announcement feels like a natural next step that formalizes an already strong connection,” he adds.
“From the launch of FINN Partners, we sought to build an agency that would amaze clients, be the best place to work, and make a difference in the world,” reflects Peter Finn, CEO and founding managing partner, of FINN Partners.
“The efforts of Mark, Christopher, Fern, Richard, Chantal and Gil working in collaboration reaffirm how agency values and the power of a united community translate into delivering extraordinary client outcomes.”
“Through their cutting-edge services, geographic reach and deep expertise in health policy research and global public health communications, Hyderus elevates our health communications strength throughout Europe,” says Chantal Bowman-Boyles, managing partner, FINN EMEA.
“The combination of Hyderus pharma and health policy knowledge and FINN’s existing diagnostics, device and digital health expertise enables us to support a broader range of EU and UK clients in the product and provider services sectors.”
"Before uniting with FINN, we worked closely with Aman Gupta and Shivani Gupta, founders of SPAG, which joined FINN last year, and we saw how the agency embraces ideas that make a difference in the world," adds Christopher Nial, a senior partner and co-lead of the EMEA public health group. “Through our work with shared clients, we have seen how FINN embraces collaboration, welcoming our expertise and counsel and truly working in close, equal partnership. Now that we have gotten to know Peter, Gil, Chantal, Fern, Richard and the FINN team, it is clear that our values align and that we can do more together.”
Chataway and Nial add their policy and process expertise to FINN clients
A well-known global communicator in the prevention of communicable diseases and better reproductive health, Chataway has led campaigns with numerous companies and international organizations, such as Gavi, the Vaccine Alliance; the Bill & Melinda Gates Foundation; London School of Hygiene and Tropical Medicine; and partnership for quality medical donations.
Nial was among the first communication leaders to recognize that project management rigour was crucial for coordinating multi-country, multi-language campaigns across regional and cultural divides.
Fern Lazar, managing partner and Global Health Practice leader says,“The COVID-era pinpointed how obstacles to access to care – including vaccine hesitancy, health technology reimbursement challenges, and inadequate treatment programs for non-communicable diseases – impact developing markets. Hyderus and FINN are best positioned to help global health clients support growth within these diverse markets.”
Offering clients a path to address global health urgencies
“As companies and communities continue to navigate constant disruption – driven by the pandemic, health urgencies, socioeconomic and environmental pressures, and new technologies – FINN has been a pioneer in recognizing that the power of collaboration is the essential launching pad for companies and governments to set a positive direction for humanity’s future,” said Gil Bashe, chair global health and purpose.